|
End-of-day quote
New Zealand S.E.
2026-10-30
|
5-day change | 1st Jan Change | ||
| 4.650 NZD | -1.06% |
|
+1.31% | +37.57% |
| Oct. 05 | ASX Preview: Australian Shares to Rise as Oil Prices Fall; Tower Lifts Fiscal 2026 Profit Guidance | MT |
| Oct. 05 | AFT Pharmaceuticals on Track for Fiscal 2027 Revenue, Profit Targets | MT |
| Market Cap | 488M 275M 246M 226M 205M 384M 26.1B 391M 2.7B 1.08B 13.73B 1.03B 1.01B 43.3B | P/E 2027 * |
24.8x | P/E 2028 * | 19.7x |
|---|---|---|---|---|---|
| Enterprise Value | 518M 292M 261M 240M 218M 407M 27.7B 415M 2.87B 1.15B 14.57B 1.09B 1.07B 45.95B | EV / Sales 2027 * |
1.7x | EV / Sales 2028 * | 1.48x |
| Free-Float |
22.37% | Yield 2027 * |
0.7% | Yield 2028 * | 0.89% |
| Markets | Quality | ||
|---|---|---|---|
New Zealand S.E.
| AFT | End-of-day quote | |
Australian S.E.
| AFP | Delayed |
Last Transcript: AFT Pharmaceuticals Limited
| 24-01-20 | Rentevrees zet Bel20 onder druk | |
| 24-01-19 | KBC uitblinker op groene beurs | |
| 24-01-19 | Brusselse beurs opent flink hoger | |
| 24-01-19 | Brussel start handelsdag vermoedelijk in het groen | |
| 24-01-18 | Hyloris gaat samenwerken met AFT Pharmaceuticals |
| 1 day | -1.06% | ||
| 1 week | +1.31% | ||
| Current month | +8.14% | ||
| 1 month | +7.14% | ||
| 3 months | -3.53% | ||
| 6 months | +32.86% | ||
| Current year | +37.57% |
| 1 week | 4.54 |  | 4.7 |
| 1 month | 4.26 | | 4.7 |
| Current year | 3.35 | | 4.85 |
| 1 year | 3.02 | | 4.85 |
| 3 years | 2.37 | | 4.85 |
| 5 years | 2.37 | | 5 |
| 10 years | 1.7 | | 5.65 |
| Manager | Title | Age | Since |
|---|---|---|---|
Marree Atkinson
HRO | Human Resources Officer | - | 2012-09-03 |
Hartley Atkinson
CEO | Chief Executive Officer | - | 1997-09-03 |
Stuart Houliston
DFI | Director of Finance/CFO | - | 2026-06-14 |
| Director | Title | Age | Since |
|---|---|---|---|
David Flacks
CHM | Chairman | - | 2015-06-21 |
Hartley Atkinson
BRD | Director/Board Member | - | 1997-09-03 |
Marree Atkinson
BRD | Director/Board Member | - | 2012-09-03 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 7/3/25 | Buy | Founder | 200,000 | 0.1907% | ||
| 6/26/25 | Free | Founder | 17,755 | 0.0169% | ||
| 12/2/24 | Buy | Founder | 45 | 0.0000% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.06% | +1.31% | +52.46% | +36.76% | 278M | |
| +3.19% | +11.31% | +67.86% | +150.58% | 1,224B | |
| -0.73% | +3.56% | +44.51% | +85.81% | 662B | |
| +1.41% | +3.24% | +29.22% | +107.83% | 514B | |
| +0.42% | +2.88% | +54.92% | +69.67% | 388B | |
| +2.18% | +2.93% | +73.30% | +45.62% | 361B | |
| +1.12% | +3.80% | +35.82% | +59.72% | 302B | |
| +6.96% | +7.55% | +11.15% | +37.89% | 271B | |
| +1.15% | +6.09% | +59.59% | +77.06% | 249B | |
| +3.06% | +9.38% | +44.11% | +119.47% | 205B | |
| Average | +1.56% | +2.35% | +47.29% | +79.04% | 417.71B | |
| Weighted average by Cap. | +1.54% | +3.04% | +51.01% | +98.65% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 304M 171M 153M 141M 128M 239M 16.26B 243M 1.68B 675M 8.55B 643M 629M 26.98B | 345M 195M 174M 160M 145M 272M 18.48B 277M 1.91B 768M 9.72B 730M 715M 30.65B |
| Net income | 19.7M 11.1M 9.94M 9.15M 8.29M 15.49M 1.05B 15.78M 109M 43.78M 555M 41.67M 40.78M 1.75B | 24.81M 13.99M 12.53M 11.52M 10.44M 19.52M 1.33B 19.88M 137M 55.16M 699M 52.49M 51.38M 2.2B |
| Net Debt | 29.84M 16.82M 15.06M 13.86M 12.55M 23.47M 1.6B 23.91M 165M 66.33M 840M 63.12M 61.77M 2.65B | 24.6M 13.87M 12.42M 11.42M 10.35M 19.35M 1.32B 19.71M 136M 54.68M 693M 52.03M 50.93M 2.18B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-29 | NZ$4.650 | -1.06% | 604 |
| 26-10-29 | NZ$4.700 | +1.29% | 4,599 |
| 26-10-28 | NZ$4.640 | +0.22% | 12,876 |
| 26-10-27 | NZ$4.630 | -0.22% | 7,972 |
| 26-10-23 | NZ$4.640 | +1.09% | 25,343 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Annual profits - Rate of surprise
- Stock Market
- Stocks
- AFT Stock
Select your edition
All financial news and data tailored to specific country editions
